439 related articles for article (PubMed ID: 21263240)
21. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
Jakobiec FA; Rai R; Lefebvre DR
Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
23. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
Aktepe F; Demir Y; Dilek FH
Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
Misago N; Narisawa Y
J Dermatol; 2006 Jan; 33(1):2-9. PubMed ID: 16469077
[TBL] [Abstract][Full Text] [Related]
25. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
D'Arcy C; Quinn C
J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
[TBL] [Abstract][Full Text] [Related]
26. [Case of clear cell hidradenoma with mucinous metaplasia in the forehead--immunohistochemical analysis of the mucin].
Ishida M; Kojima F; Kushima R; Kakutani A; Okabe H
Rinsho Byori; 2006 Aug; 54(8):781-4. PubMed ID: 16989395
[TBL] [Abstract][Full Text] [Related]
27. Myoepithelial cell layer integrity in canine mammary carcinoma.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
[TBL] [Abstract][Full Text] [Related]
28. Encapsulated apocrine papillary carcinoma of the breast: case report with clinicopathologic and immunohistochemical study.
Laforga JB; Gasent JM; Sánchez I
Diagn Cytopathol; 2011 Apr; 39(4):288-93. PubMed ID: 20734358
[TBL] [Abstract][Full Text] [Related]
29. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
30. An unusual tumor of the female breast: combined eccrine and apocrine spiradenoma.
Zawirska B; Cisek T; Markuszewska-Bednarz J
Patol Pol; 1983; 34(1):125-8. PubMed ID: 6310473
[No Abstract] [Full Text] [Related]
31. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
Vincent-Salomon A
Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
[No Abstract] [Full Text] [Related]
32. Apocrine adenomyoepithelioma--a rare but distinctive primary sweat gland neoplasm.
Sabater Marco V
J Cutan Pathol; 2012 Jul; 39(7):701-6. PubMed ID: 22612240
[TBL] [Abstract][Full Text] [Related]
33. [Breast carcinoma, apocrine variety].
Guidugli Neto J; Kogos W
Rev Paul Med; 1990; 108(5):239-40. PubMed ID: 1966399
[TBL] [Abstract][Full Text] [Related]
34. Squamous cell apocrine hidradenoma.
Angulo J; Jaqueti G; Kutzner H; Requena L
J Cutan Pathol; 2007 Oct; 34(10):801-3. PubMed ID: 17880588
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
[TBL] [Abstract][Full Text] [Related]
36. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
37. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
39. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous apocrine mixed tumor with intravascular tumor deposits: a diagnostic pitfall.
Kazakov DV; Kacerovska D; Skalova A; Zelger B; Schaller J; Shelekhova K; Michal M
Am J Dermatopathol; 2011 Dec; 33(8):775-9. PubMed ID: 21785330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
